Cargando…
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
SARS-CoV-2, the agent of COVID-19, shares a lineage with SARS-CoV-1, and a common fatal pulmonary profile but with striking differences in presentation, clinical course, and response to treatment. In contrast to SARS-CoV-1 (SARS), COVID-19 has presented as an often bi-phasic, multi-organ pathology,...
Autores principales: | Gan, Rosemary, Rosoman, Nicholas P., Henshaw, David J.E., Noble, Euan P., Georgius, Peter, Sommerfeld, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308773/ https://www.ncbi.nlm.nih.gov/pubmed/32758871 http://dx.doi.org/10.1016/j.mehy.2020.110024 |
Ejemplares similares
-
ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010) -
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
por: Roca-Ho, Heleia, et al.
Publicado: (2017) -
Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007) -
Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012) -
ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells
por: Fernando, Sudini R., et al.
Publicado: (2022)